[Invasive therapeutic strategies in acute heart failure complicating coronary artery disease: effectiveness and

Related Experiment Video

Updated: Jul 18, 2026

Testing Acetylcholine Followed by Adenosine for Invasive Diagnosis of Coronary Vasomotor Disorders
05:58

Testing Acetylcholine Followed by Adenosine for Invasive Diagnosis of Coronary Vasomotor Disorders

Published on: February 3, 2021

Tudor C Poerner1, Markus Ferrari, Bernhard R Brehm

  • 1Klinik für Innere Medizin I, Friedrich-Schiller-Universität, Erlanger Allee 101, 07747, Jena. tpoerner@googlemail.com

Herz
|December 7, 2006
PubMed

Insights

Acute myocardial infarction (MI) with cardiogenic shock can be fatal. Mechanical circulatory support devices and revascularization improve survival by stabilizing patients for procedures like percutaneous coronary intervention.

Area of Science:

  • Cardiology
  • Cardiovascular Surgery
  • Critical Care Medicine

Context:

  • Acute myocardial infarction (MI) frequently leads to cardiogenic shock, a life-threatening condition.
  • Despite advancements, cardiogenic shock remains a significant cause of mortality in acute MI patients.
  • Mechanical reperfusion via percutaneous coronary intervention (PCI) or coronary artery bypass graft (CABG) surgery is crucial for survival.

Purpose:

  • To provide an overview of therapeutic strategies for acute MI with cardiogenic shock.
  • To highlight the role of mechanical circulatory support devices in managing these critical patients.
  • To discuss the specific applications and benefits of various support devices.

Summary:

  • Acute heart failure and cardiogenic shock are common causes of death in acute myocardial infarction (MI).
  • Mechanical reperfusion through PCI or CABG surgery significantly improves survival rates in patients with acute MI and cardiogenic shock.
  • Intraaortic balloon pump (IABP) support and ventricular assist devices are vital for hemodynamic stabilization, enabling safe revascularization procedures.

Impact:

  • Improved patient outcomes in acute MI complicated by cardiogenic shock.
  • Enhanced understanding of mechanical circulatory support device selection and utilization.
  • Guidance for clinicians on optimizing therapeutic strategies for high-risk MI patients.

More Related Videos

Cell-based Therapy for Heart Failure in Rat: Double Thoracotomy for Myocardial Infarction and Epicardial Implantation of Cells and Biomatrix09:11

Cell-based Therapy for Heart Failure in Rat: Double Thoracotomy for Myocardial Infarction and Epicardial Implantation of Cells and Biomatrix

Published on: September 22, 2014

Interventional Diagnostic Procedure: A Practical Guide for the Assessment of Coronary Vascular Function10:28

Interventional Diagnostic Procedure: A Practical Guide for the Assessment of Coronary Vascular Function

Published on: March 15, 2022

Related Concept Videos

Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
Heart Failure VI: Adjunct Therapies01:22

Heart Failure VI: Adjunct Therapies

Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System01:26

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
Heart Failure V: Medical Management01:30

Heart Failure V: Medical Management

Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
Angina IV: Management01:26

Angina IV: Management

IntroductionThe management of angina requires a comprehensive approach that includes pharmacological therapies, medical procedures, and lifestyle modifications.Pharmacological TherapiesAntiplatelet agents, such as aspirin, clopidogrel, prasugrel, and ticagrelor, play a pivotal role in preventing thrombus formation in patients with angina. These medications inhibit platelet aggregation and reduce the likelihood of myocardial infarction and other cardiovascular events.Anticoagulants, including...